INT46302

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.36
First Reported 1982
Last Reported 2006
Negated 0
Speculated 0
Reported most in Abstract
Documents 6
Total Number 6
Disease Relevance 2.37
Pain Relevance 0.70

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Anatomy Link Frequency
sting 1
CPA 1
nasal 1
sar (Mus musculus)
Pain Link Frequency Relevance Heat
agonist 5 100.00 Very High Very High Very High
antagonist 3 100.00 Very High Very High Very High
Antihistamine 4 98.98 Very High Very High Very High
Cannabinoid 5 93.76 High High
Analgesic 2 85.76 High High
Pain 5 81.28 Quite High
Cannabinoid receptor 2 75.00 Quite High
Paracetamol 2 50.00 Quite Low
headache 5 25.00 Low Low
rheumatoid arthritis 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Hypersensitivity 58 100.00 Very High Very High Very High
Rhinitis 15 100.00 Very High Very High Very High
Bites And Stings 25 98.48 Very High Very High Very High
Vomiting 1 84.40 Quite High
Pain 1 81.28 Quite High
Cancer 1 80.96 Quite High
Glaucoma 1 77.92 Quite High
Insect Bites And Stings 7 75.00 Quite High
Disease 1 73.84 Quite High
Traumatic Stress Disorders 1 67.20 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
It is found that all the data can be satisfactorily described by a single power function expression which gives the exposure duration as a function of the SAR in the critical organ and an experiment-specific constant.
SAR Binding (function) of
1) Confidence 0.36 Published 1982 Journal J Microw Power Section Abstract Doc Link 6925591 Disease Relevance 0.08 Pain Relevance 0.08
CONCLUSIONS: Treatment with CPA was safe and highly effective in reducing symptoms associated with SAR.
SAR Binding (associated) of in CPA
2) Confidence 0.35 Published 2003 Journal Ann. Allergy Asthma Immunol. Section Body Doc Link 12546342 Disease Relevance 0 Pain Relevance 0
Although antihistamines are highly effective in alleviating many symptoms associated with seasonal allergic rhinitis (SAR), relief from nasal congestion is variable.
SAR Binding (associated) of in nasal associated with rhinitis and antihistamine
3) Confidence 0.32 Published 2005 Journal Allergy Asthma Proc Section Abstract Doc Link 16450574 Disease Relevance 0.41 Pain Relevance 0.10
Omalizumab, a novel humanized monoclonal anti-immunoglobulin E (IgE) antibody, has already been proven to reduce symptoms associated with SAR.
SAR Binding (associated) of associated with rhinitis
4) Confidence 0.22 Published 2006 Journal Allergol Int Section Abstract Doc Link 17130680 Disease Relevance 0.36 Pain Relevance 0
Increased risk of experiencing SAR to a future sting in wasp allergic patients after cessation of adequate IT was significantly associated with a SAR due to IT during the rush regimen.
SAR Binding (associated) of in sting associated with bites and stings and hypersensitivity
5) Confidence 0.15 Published 2005 Journal Clin Mol Allergy Section Abstract Doc Link PMC1208928 Disease Relevance 1.06 Pain Relevance 0
An extensive amount of SAR has been developed for agonists and antagonists that bind at CB1, while the SAR of CB2 ligands is only now emerging in the literature.
SAR Binding (bind) of associated with antagonist and agonist
6) Confidence 0.04 Published 2003 Journal Curr. Pharm. Des. Section Abstract Doc Link 12871061 Disease Relevance 0.45 Pain Relevance 0.52

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox